Multiple homeostatic systems are regulated by orexin (hypocretin) peptides and their two known GPCRs. Activation of orexin receptors promotes waking and is essential for expression of normal sleep and waking behaviour, with the sleep disorder narcolepsy resulting from the absence of orexin signalling. Orexin receptors also influence systems regulating appetite/metabolism, stress and reward, and are found in several peripheral tissues. Nevertheless, much remains unknown about the signalling pathways and targets engaged by native receptors. In this review, we integrate knowledge about the orexin receptor signalling capabilities obtained from studies in expression systems and various native cell types (as presented in Kukkonen and Leonard, this issue of British Journal of Pharmacology) with knowledge of orexin signalling in different tissues. The tissues reviewed include the CNS, the gastrointestinal tract, the pituitary gland, pancreas, adrenal gland, adipose tissue and the male reproductive system. We also summarize the findings in different native and recombinant cell lines, especially focusing on the different cascades in CHO cells, which is the most investigated cell line. This reveals that while a substantial gap exists between what is known about orexin receptor signalling and effectors in recombinant systems and native systems, mounting evidence suggests that orexin receptor signalling is more diverse than originally thought. Moreover, rather than being restricted to orexin receptor 'overexpressing' cells, this signalling diversity may be utilized by native receptors in a site-specific manner.
LINKED ARTICLESThis article is part of a themed section on Orexin Receptors. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-2 Abbreviations 2-AG, 2-arachidonoylglycerol; AA, arachidonic acid; (s)AHP, (slow) afterhyperpolarization; AR42J, a rat pancreatic acinar tumour cell line; BAPTA, 1,2-bis(O-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; Caco-2, HT29-D4, LoVo and SW480, human colon carcinoma cell lines, cPLA2, cytosolic (Ca 2+ -sensitive) phospholipase A2; DGL, DAG lipase; H-current, a non-selective cation current mediated by hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels; HSD3B2, 3β-hydroxysteroid dehydrogenase; IMR-32 and SK-N-MC, human neuroblastoma cell lines; IP3, inositol-1,4,5-trisphosphate; IsAHP, sAHP current; Kir channels, inward rectifier K + channels; MEF, mouse embryonic fibroblast; MEK1, MAPK/ERK kinase 1; NCX, Na + /Ca 2+ -exchanger; neuro-2a, a mouse neuroblastoma cell line; nPKC, novel PKC; NSCC, non-selective cation channel; OX1 and OX2, OX1 and OX2 orexin receptors, respectively; PC12, a rat pheochromocytoma cell line; PIP, phosphatidylinositol-4-phosphate; PIP2, phosphatidylinositol-4,5-bisphosphate; TRP (channel), transient receptor potential (channel); VGCC, voltage-gated Ca 2+ channel
IntroductionThe landmark discoveries of the orexin (hypocretin) peptides (orexin-A and orexin-B) and their two known GPCRs (OX1 and OX2 recep...